After IBM announced interest then pulled back, today brought news that Oracle plans to buy Sun Microsystems for over $7 billion (click here for Bloomberg report) brings interesting questions on what new enabling technologies might soon available for drug R&D and manufacturing. A recent article in Computer Weekly examined IT's evolution in life sciences, from ancillary to critical tool.
AMS
About the Author
pharmamanufacturing
pharmamanufacturing
Sign up for our eNewsletters
Get the latest news and updates